Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

THE TRUTH ABOUT: 3 - Caught on Camera

These Are The Top Cannabis Stock Picks According To 3 Of The Top Equity Analysts In The Marijuana Market

What are the best cannabis stocks to invest in right now?

Benzinga

OrganiGram Beat Fact Set Expectations: "The Stock Represents Good Value," Analyst Says

On Thursday, Organigram Holdings Inc. (OGI.TO) (NASDAQ: OGI), a cannabis company focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada,

Benzinga

Medical Marijuana Sales In US Plunge As Recreational Biz Bounces Back, Analyst Opines On Ways To Build Market Resilience

Federal legalization of cannabis seems to be moving slowly. However, states are lifting their bans on both medical and recreational marijuana one by one.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Cantor's Top Picks: Could Q2 Earnings Provide A Spark For These Cannabis Multi-State Operators?

Multi-State Operators (MSO) traded higher on Tuesday after Cantor Fitzgerald categorized four companies as "top picks." In a recent industry report, Pablo Zuanic analyzed the context of MSOs and offered insight on trends driving financial value. Although MSOs ETF fell 25% in June and 49% over the last three months (vs.

Benzinga

Sentiment For Tilray Stock Should Improve, This Analyst Tells Us Why

Germany is inching toward legalizing recreational cannabis as the government seeks to have the process completed by the end of 2022. The latest push is coming from the country’s Health Ministry which undertook exper

Benzinga

HEXO Deal Could Be A Big Win For Tilray, This Analyst Tells Us Why

On Wednesday HEXO Corp (NASDAQ: HEXO) reported a staggering loss of CA$152.7 million ($118 million) in the third quarter of 2022, representing a

Benzinga

High Tide: 'Continued Progress, But More Operational Leverage Needed,' Analyst Says

The Analyst Pablo Zuanic from Cantor Fitzgerald remained ‘Neutral' on High Tide Inc. (NASDAQ: HITI) and lowered the stock 12-month price target to C$4.45 from C$7 “given overall sectoral derating.”

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Is A Compromise On The Horizon? Why Schumer Might Act On Cannabis Banking Sooner Rather Than Later

The Senate has been under pressure from all sides recently to pass the SAFE Banking Act that would "help cannabis-related businesses, support innovation, create jobs, and strengthen public safety in our com

Benzinga

Top Cannabis Companies By Revenue In May, Marijuana Stocks To Check Out As Earnings Season Fades

As another earnings season draws to a close, investors in cannabis stocks have gone through some trying times.

Benzinga

After A Challenging March Quarter Canopy Growth Projects Positive EBITDA By FY 2024

Pablo Zuanic from Cantor Fitzgerald kept a rating of “Neutral” for the stocks of Canopy Growth Corp. (TSE: WEED) (NASDAQ: CGC) and lowered his 12-month price target to C$6.75 from C$7.75 due to the sectoral derating and red

Benzinga

Analyst Says New Jersey Rec Marijuana Market Holds High Potential Despite Slow Start, Here's Why

New Jerseyans spent $24 million on weed during the first month of recreational sales, roughly $5 million a week after a record-breaking first day when

Benzinga

AYR Wellness: Management Expects 'Significant Sales' And 'EBITDA Ramp' In 2022

The Analyst Pablo Zuanic from Cantor Fitzgerald kept a rating of "Neutral" on Ayr Wellness Inc. (OTC: AYRWF) stocks and lowered its 12-month price target to $6.75 from $13.30, due to reduced estimates and overall sectoral derating.

Benzinga

Cannabis Reform Is 'By Far The Main Catalyst,' Analyst Discusses Jushi's Q4 Financial Results

Jushi Holdings Inc. (OTCQX: JUSHF) (CSE:JUSH) released its financial results for the first quarter of 2022 ended March 31, 2022, revealing revenue of $61

Benzinga

Jim Cramer Explains What Needs To Happen For Cannabis Stocks To Bounce Back

Cannabis investors are in the midst of earnings season, which is also a timely opportunity to take a glimpse at the stock performance of some big players within the space.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Acreage Holdings Is An Arbitrage Play, This Analyst Explains Why

Acreage Holdings, Inc (OTC: ACRDF) recently posted its financial results for the first quarter ended March 31, 2022.

Benzinga

Cresco Lab's 1Q Results After Conference Call, Analyst Opines

The Analyst Following Cresco Labs’ (OTC: CRLBF) (CSE:CL) conference call, Pablo Zuanic, from Cantor Fitzgerald kept an "Overweight" rating and maintained a 12-month price target of $19.

Benzinga

Charlotte's Web Is Still Much Of A 'Show Me Story', Analyst Explains Why

The Analyst

Benzinga

Here's Why Investors Should Keep An Eye On Sundial Stock, Analyst's Thoughts Post Q1 Earnings

On Monday, Canadian cannabis LP Sundial Growers Inc. (NASDAQ: SNDL) released its

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Columbia Care: Challenging 1Q, Stock Is Now Tied to Cresco Deal Analyst Says

The Analyst Pablo Zuanic, from Cantor Fitzgerald, rated Columbia Care Inc. (OTC: CCHWF) as Overweight with a price target of $5.10.

Benzinga

This Cannabis MSO Stock Is Attractively Valued & Well Positioned To Capitalize On Market Opportunities, Analyst Explains Why

Trulieve Cannabis Corp. (OTCQX: TCNNF) (CSE:TRUL) reported its financial results for the first quarter on Thursday.

Benzinga

TerrAscend To See Top-Line & Margin Improvement In 2022, Analyst's Thoughts Post Q1 Earnings

TerrAscend Corp. (CSE: TER)(OTCQX: TRSSF) reported its first-quarter financial results late Thursday, reporting net sales of $49.7 million, up 1% sequentially.

Benzinga

This Cannabis Stock Is Analyst's Top Pick Among Canadian LP Group, Here's Why

Village Farms International, Inc. (NASDAQ: VFF) reported Tuesday that its consolidated sales increased 34% year-over-year to $70.2 million in the f

Benzinga

Is It Time To Invest In Curaleaf? Analyst Shares Perspective Post Q1 Earnings

Curaleaf Holdings, Inc. (OTC: CURLF) reported its financial and operating results late Monday for the first quarter ended March 31, 2022, revealing revenue of $313 million, up 20% YoY.

Benzinga

This Weedmaps Analyst Sees These 'Tailwinds' For Cannabis Tech Provider After Q1 Earnings

Cannabis tech provider WM Technology Inc. (NASDAQ: MAPS), more commonly known as Weedmaps,

Benzinga

Green Thumb Industries Analyst On Q1 Earnings: Cannabis Grower Has Enough Cash To Fuel Growth

Green Thumb Industries Inc. (OTCQX: GTBIF) (CSE: GTII) reported its

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.